Literature DB >> 12818435

An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies.

J C Gillham1, L C Kenny, P N Baker.   

Abstract

Normal pregnancy is associated with decreased peripheral vascular resistance, although the mechanisms are poorly understood. Pre-eclampsia is characterised by increased vessel resistance and a decreased relaxant capacity, contributing to the associated hypertension, multi-organ damage and intra-uterine growth restriction. An endothelium-derived vasoactive substance-endothelium-derived hyperpolarising factor may be responsible for the physiological changes in the maternal vasculature. This is a review of the current understanding of the complexities of vessel behaviour. Evidence is reviewed to support the possible contribution of endothelium-derived hyperpolarising factor to the compromised vascular state in pre-eclampsia. This is an important area of research which may help to understand further the pathogenesis of this specific pregnancy related disease, that contributes greatly to maternal and fetal morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818435     DOI: 10.1016/s0301-2115(03)00044-7

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  10 in total

1.  Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries.

Authors:  Vijayakumar Chinnathambi; Chellakkan S Blesson; Kathleen L Vincent; George R Saade; Gary D Hankins; Chandra Yallampalli; Kunju Sathishkumar
Journal:  Hypertension       Date:  2014-05-19       Impact factor: 10.190

2.  Resistance artery adaptation to pregnancy counteracts the vasoconstricting influence of plasma from normal pregnant women.

Authors:  Odül A Amburgey; Shane A Reeves; Ira M Bernstein; Marilyn J Cipolla
Journal:  Reprod Sci       Date:  2009-09-18       Impact factor: 3.060

3.  Testosterone alters maternal vascular adaptations: role of the endothelial NO system.

Authors:  Vijayakumar Chinnathambi; Meena Balakrishnan; Jayanth Ramadoss; Chandrasekhar Yallampalli; Kunju Sathishkumar
Journal:  Hypertension       Date:  2013-01-21       Impact factor: 10.190

4.  Alteration of skin laser-Doppler flux response to local cooling in gestational hypertension.

Authors:  Ksenija Cankar; Nejka Potocnik; Martin Strucl
Journal:  Clin Auton Res       Date:  2010-01-09       Impact factor: 4.435

5.  The SK3 channel promotes placental vascularization by enhancing secretion of angiogenic factors.

Authors:  Cara C Rada; Grace Murray; Sarah K England
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

6.  Uteroplacental insufficiency programmes vascular dysfunction in non-pregnant rats: compensatory adaptations in pregnancy.

Authors:  Marc Q Mazzuca; Marianne Tare; Helena C Parkington; Nicoleta M Dragomir; Laura J Parry; Mary E Wlodek
Journal:  J Physiol       Date:  2012-05-14       Impact factor: 5.182

Review 7.  The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Authors:  Kirk P Conrad; John M Davison
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

Review 8.  Androgens in maternal vascular and placental function: implications for preeclampsia pathogenesis

Authors:  Sathish Kumar; Geoffrey H Gordon; David H Abbott; Jay S Mishra
Journal:  Reproduction       Date:  2018-10-16       Impact factor: 3.906

9.  Endothelium-dependent relaxation and angiotensin II sensitivity in experimental preeclampsia.

Authors:  Anne Marijn van der Graaf; Marjon J Wiegman; Torsten Plösch; Gerda G Zeeman; Azuwerus van Buiten; Robert H Henning; Hendrik Buikema; Marijke M Faas
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

10.  The direct and sustained consequences of severe placental hypoxia on vascular contractility.

Authors:  Philippe Vangrieken; Salwan Al-Nasiry; Ger M J Janssen; Antje R Weseler; Marc E Spaanderman; Aalt Bast; Paul M H Schiffers
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.